FDAFDA · Food and drugs·Recall number D-1052-2014
Sermorelin/GHRP-6, 3 mg/3 mg, 5 mL vial, Stock # 21740, Compounded by NuVision Pharmacy, Dallas, TX 75244
Published February 5, 2014 · Recall initiated: April 15, 2013
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: The recall is being initiated due to a lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Manufacturer
- NuVision Pharmacy, Inc.
- Distributor
- Nationwide
- Lot
- Lot #:N10172012@11, Exp 10/17/2013
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.